Martin Viertelhaus

This inventor holds 14 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Basf Se Corporation, Anadys Pharmaceuticals, Inc., Takeda Gmbh. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Viertelhaus. Retrieved from https://idiyas.com/inventor/martin-viertelhaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 8)

% Patents Active = 42.9

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 16)

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Basel, DE (2011)
Wittlich, DE (2012 - 2013)
Konstanz, DE (2015)
Constance, DE (2015 - 2016)
Mannheim, DE (2018)
Ludwigshafen am Rhein, DE (2023)
Ludwigshafen, DE (2022 - 2024)

Company Filing History:

Anadys Pharmaceuticals, Inc.

Years Active: 2011-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435065 - Crystalline forms of 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide (2025-10-07),

2. 11897847 - Crystalline form of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate (2024-02-13),

3. 11685759 - Method for obtaining crystalline 2'-fucosyllactose (2023-06-27),

4. 11311014 - Crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (2022-04-26),

5. 11292784 - Crystalline forms of ethyl 2-[[3-[[3- chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy] acetate (2022-04-05),

6. 10105355 - Multi-component crystals of vismodegib and selected co-crystal formers or solvents (2018-10-23),

7. 10053436 - Process for the preparation of substituted oxiranes and triazoles (2018-08-21),

8. 10045998 - Solid form of abiraterone acetate (2018-08-14),

9. 9376442 - Methylpyrrolopyrimidinecarboxamides (2016-06-28),

10. 9006431 - Crystalline form of pemirolast (2015-04-14),

11. 8927557 - Methylpyrrolopyrimidinecarboxamides (2015-01-06),

12. 8546602 - 5,6-D hydro-1H-pyridin-2-one compounds (2013-10-01),

13. 8101800 - [object Object] (2012-01-24),

14. 7928085 - P-toluene sulfonic acid salt of 5-amino-3-(2'-O-acetyl-3′-deoxy-β-D-ribofuranosyl)-3H-thiazole[4,5-d]pyrimidine-2-one and methods for preparation (2011-04-19),

Title: **Innovative Contributions of Martin Viertelhaus in the Field of Patents**

Introduction

Martin Viertelhaus, based in Mannheim, Germany, is an esteemed inventor recognized for his significant contributions, holding a total of 10 patents. His work primarily revolves around advancements in chemical formulations and methods, particularly in the areas of plant protection and carbohydrate chemistry.

Latest Patents

Among his most recent patents is the invention of a crystalline form of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate. This patent encapsulates a process for producing this crystalline form, along with formulations for plant protection and herbicidal compositions that incorporate this specific crystalline variant.

Another significant patent pertains to a method for obtaining crystalline 2'-fucosyllactose from a raw material rich in 2'-FL. This method emphasizes the crystallization process under controlled supersaturation conditions, ensuring the purity and quality of the final crystalline product.

Career Highlights

Throughout his professional journey, Martin has collaborated with prominent companies, including BASF SE Corporation and Anadys Pharmaceuticals, Inc. His work at these companies has been instrumental in bridging the gap between creative ideas and practical applications in the industry.

Collaborations

Martin Viertelhaus has collaborated with several esteemed colleagues, such as Fritz Blatter and David J Kucera. Their joint efforts in research and development have fostered a vibrant innovation landscape, contributing to the rich tapestry of advancements seen in their respective fields.

Conclusion

In conclusion, Martin Viertelhaus exemplifies the spirit of innovation through his patents and collaborative work. His contributions in the realm of chemical formulations and methods not only showcase his inventiveness but also highlight the importance of collaboration in advancing science and technology.

Profile summary based on public USPTO records.